Be a PRO & get up to 50% off on select brands. Explore Now
you are here: HomeNewsBusiness

Gland Pharma Q4 PAT seen up 17.3% YoY to Rs. 229 cr: Sharekhan

Net Sales are expected to increase by 30 percent Y-o-Y (down 3.9 percent Q-o-Q) to Rs. 825.8 crore, according to Sharekhan.

April 12, 2021 / 09:14 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan has come out with its fourth quarter (January-March’ 21) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Gland Pharma to report net profit at Rs. 229 crore up 17.3% year-on-year (up 12.2% quarter-on-quarter).


Net Sales are expected to increase by 30 percent Y-o-Y (down 3.9 percent Q-o-Q) to Rs. 825.8 crore, according to Sharekhan.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research

stay updated

Get Daily News on your Browser
Sections
Enjoying Moneycontrol?

How about a quick survey to help us improve our services?

Ok, sure

Maybe next time!